234 related articles for article (PubMed ID: 24603303)
21. Targeted Suppression and Knockout of ASCT2 or LAT1 in Epithelial and Mesenchymal Human Liver Cancer Cells Fail to Inhibit Growth.
Bothwell PJ; Kron CD; Wittke EF; Czerniak BN; Bode BP
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30029480
[TBL] [Abstract][Full Text] [Related]
22. Glutamine availability up-regulates expression of the amino acid transporter protein ASCT2 in HepG2 cells and stimulates the ASCT2 promoter.
Bungard CI; McGivan JD
Biochem J; 2004 Aug; 382(Pt 1):27-32. PubMed ID: 15175006
[TBL] [Abstract][Full Text] [Related]
23. Thymidylate synthase expression is closely associated with outcome in patients with pulmonary adenocarcinoma.
Kaira K; Ohde Y; Nakagawa K; Okumura T; Murakami H; Takahashi T; Kondo H; Nakajima T; Endo M; Yamamoto N
Med Oncol; 2012 Sep; 29(3):1663-72. PubMed ID: 21948461
[TBL] [Abstract][Full Text] [Related]
24. Genetic Variants in ASCT2 Gene are Associated with the Prognosis of Transarterial Chemoembolisation-Treated Early- Stage Hepatocelluar Carcinoma.
Ge NJ; Shi ZY; Yu XH; Huang XJ; Wu YS; Chen YY; Zhang J; Yang YF
Asian Pac J Cancer Prev; 2015; 16(9):4103-7. PubMed ID: 25987094
[TBL] [Abstract][Full Text] [Related]
25. Preclinical Evaluation of 4-[18F]Fluoroglutamine PET to Assess ASCT2 Expression in Lung Cancer.
Hassanein M; Hight MR; Buck JR; Tantawy MN; Nickels ML; Hoeksema MD; Harris BK; Boyd K; Massion PP; Manning HC
Mol Imaging Biol; 2016 Feb; 18(1):18-23. PubMed ID: 25971659
[TBL] [Abstract][Full Text] [Related]
26. ATF4 and N-Myc coordinate glutamine metabolism in MYCN-amplified neuroblastoma cells through ASCT2 activation.
Ren P; Yue M; Xiao D; Xiu R; Gan L; Liu H; Qing G
J Pathol; 2015 Jan; 235(1):90-100. PubMed ID: 25142020
[TBL] [Abstract][Full Text] [Related]
27. Ablation of the
Bröer A; Gauthier-Coles G; Rahimi F; van Geldermalsen M; Dorsch D; Wegener A; Holst J; Bröer S
J Biol Chem; 2019 Mar; 294(11):4012-4026. PubMed ID: 30635397
[TBL] [Abstract][Full Text] [Related]
28. ASC amino acid transporter 2, defined by enzyme-mediated activation of radical sources, enhances malignancy of GD2-positive small-cell lung cancer.
Esaki N; Ohkawa Y; Hashimoto N; Tsuda Y; Ohmi Y; Bhuiyan RH; Kotani N; Honke K; Enomoto A; Takahashi M; Furukawa K; Furukawa K
Cancer Sci; 2018 Jan; 109(1):141-153. PubMed ID: 29151270
[TBL] [Abstract][Full Text] [Related]
29. Clinical Role of ASCT2 (SLC1A5) in KRAS-Mutated Colorectal Cancer.
Toda K; Nishikawa G; Iwamoto M; Itatani Y; Takahashi R; Sakai Y; Kawada K
Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28749408
[TBL] [Abstract][Full Text] [Related]
30. CD98 expression is associated with poor prognosis in resected non-small-cell lung cancer with lymph node metastases.
Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Kawashima O; Kamide Y; Ishizuka T; Kanai Y; Nakajima T; Mori M
Ann Surg Oncol; 2009 Dec; 16(12):3473-81. PubMed ID: 19777189
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of SLC1a5 in lymph node metastases outperforms assessment in the primary as a negative prognosticator in non-small cell lung cancer.
Csanadi A; Oser A; Aumann K; Gumpp V; Rawluk J; Nestle U; Kayser C; Wiesemann S; Werner M; Kayser G
Pathology; 2018 Apr; 50(3):269-275. PubMed ID: 29455869
[TBL] [Abstract][Full Text] [Related]
32. The role of ASCT2 in cancer: A review.
Liu Y; Zhao T; Li Z; Wang L; Yuan S; Sun L
Eur J Pharmacol; 2018 Oct; 837():81-87. PubMed ID: 30025811
[TBL] [Abstract][Full Text] [Related]
33. Relationship between CD147 and expression of amino acid transporters (LAT1 and ASCT2) in patients with pancreatic cancer.
Kaira K; Arakawa K; Shimizu K; Oriuchi N; Nagamori S; Kanai Y; Oyama T; Takeyoshi I
Am J Transl Res; 2015; 7(2):356-63. PubMed ID: 25901202
[TBL] [Abstract][Full Text] [Related]
34. Inducible antisense RNA targeting amino acid transporter ATB0/ASCT2 elicits apoptosis in human hepatoma cells.
Fuchs BC; Perez JC; Suetterlin JE; Chaudhry SB; Bode BP
Am J Physiol Gastrointest Liver Physiol; 2004 Mar; 286(3):G467-78. PubMed ID: 14563674
[TBL] [Abstract][Full Text] [Related]
35. Topotecan induces apoptosis via ASCT2 mediated oxidative stress in gastric cancer.
Wang L; Liu Y; Zhao TL; Li ZZ; He JY; Zhang BJ; Du HZ; Jiang JW; Yuan ST; Sun L
Phytomedicine; 2019 Apr; 57():117-128. PubMed ID: 30668314
[TBL] [Abstract][Full Text] [Related]
36. ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer.
van Geldermalsen M; Wang Q; Nagarajah R; Marshall AD; Thoeng A; Gao D; Ritchie W; Feng Y; Bailey CG; Deng N; Harvey K; Beith JM; Selinger CI; O'Toole SA; Rasko JE; Holst J
Oncogene; 2016 Jun; 35(24):3201-8. PubMed ID: 26455325
[TBL] [Abstract][Full Text] [Related]
37. The role of the glutamine transporter ASCT2 in antineoplastic therapy.
Teixeira E; Silva C; Martel F
Cancer Chemother Pharmacol; 2021 Apr; 87(4):447-464. PubMed ID: 33464409
[TBL] [Abstract][Full Text] [Related]
38. Kinetic analyses of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid transport in Xenopus laevis oocytes expressing human ASCT2 and SNAT2.
Okudaira H; Nakanishi T; Oka S; Kobayashi M; Tamagami H; Schuster DM; Goodman MM; Shirakami Y; Tamai I; Kawai K
Nucl Med Biol; 2013 Jul; 40(5):670-5. PubMed ID: 23647854
[TBL] [Abstract][Full Text] [Related]
39. Targeting glutamine transport to suppress melanoma cell growth.
Wang Q; Beaumont KA; Otte NJ; Font J; Bailey CG; van Geldermalsen M; Sharp DM; Tiffen JC; Ryan RM; Jormakka M; Haass NK; Rasko JE; Holst J
Int J Cancer; 2014 Sep; 135(5):1060-71. PubMed ID: 24531984
[TBL] [Abstract][Full Text] [Related]
40. [Effect of ASCT2 gene knock-down by shRNA on biological behaviors of colorectal cancer cells].
Cai C; Zeng B; Zeng J; Xin H; Tang C
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):450-454. PubMed ID: 28440528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]